Weekly Gemcitabine and Docetaxel in Refractory Soft Tissue Sarcoma: A Retrospective Analysis

PURPOSE: The combination of gemcitabine and docetaxel (GD) is used to effectively treat patients with soft tissue sarcoma (STS). It is widely considered that the conventional doses used are too high for long term use and many patients must discontinue GD treatment due to its toxicity. Therefore, to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ha-young, Shin, Sang Joon, Kim, Hyo Song, Hong, Soo Jung, Han, Jung Woo, Lim, Seung Taek, Roh, Jae Kyung, Rha, Sun Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322200/
https://www.ncbi.nlm.nih.gov/pubmed/22500160
http://dx.doi.org/10.4143/crt.2012.44.1.43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322200/
https://www.ncbi.nlm.nih.gov/pubmed/22500160
http://dx.doi.org/10.4143/crt.2012.44.1.43

Ejemplares similares